SCYL2 and gastric cancer: Liu, H et al. confirmed that EPRS bound with SCYL2 to enhance activation of the WNT/GSK-3β/β-catenin signaling pathway and accumulation of β-catenin in nuclear, leading to gastric cancer cell proliferation and growth (Liu et al. 2021).